OrbiMed’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-550,114
Closed -$54.2M 156
2021
Q1
$54.2M Hold
550,114
0.51% 55
2020
Q4
$59.6M Buy
550,114
+91,680
+20% +$9.94M 0.52% 54
2020
Q3
$47.2M Buy
458,434
+129,360
+39% +$13.3M 0.59% 54
2020
Q2
$68.7M Sell
329,074
-15,990
-5% -$3.34M 0.97% 31
2020
Q1
$33.7M Sell
345,064
-89,155
-21% -$8.71M 0.57% 47
2019
Q4
$50M Buy
434,219
+32,922
+8% +$3.79M 0.71% 45
2019
Q3
$21.9M Buy
401,297
+205,277
+105% +$11.2M 0.42% 57
2019
Q2
$23.3M Buy
196,020
+71,700
+58% +$8.53M 0.36% 61
2019
Q1
$6.51M Buy
+124,320
New +$6.51M 0.1% 94
2015
Q3
Hold
0
130
2015
Q2
Sell
-28,390
Closed -$11.5M 126
2015
Q1
$11.5M Buy
+28,390
New +$11.5M 0.1% 93